Abstract:(−)‐Finerenone is a nonsteroidal mineralocorticoid receptor antagonist currently in phase III clinical trials for the treatment of chronic kidney disease in type 2 diabetes. It contains an unusual dihydronaphthyridine core. We report a 6‐step synthesis of (−)‐finerenone, which features an enantioselective partial transfer hydrogenation of a naphthyridine using a chiral phosphoric acid catalyst with a Hantzsch ester. The process is complicated by the fact that the naphthyridine exists as a mixture of two atropi… Show more
“…In their patent that described the electrochemical process, Bayer inventors noted that pyridine 15 exists as a mixture of two atropisomers due to hindered rotation. , The electrochemical or chemical oxidation of the undesired enantiomer ( R )- 14 leads to an ( R )- 15 :( S )- 15 ratio of about 15:85. Electrochemical reduction of this mixture leads to a similar ( S )- 15 :( R )- 15 ratio, thereby regenerating a high percentage of the undesired ( R )- 14 enantiomer.…”
Flow chemistry reactions and continuous separations have become established processing modalities in the pharmaceutical industry from early development to manufacturing. The current review highlights patents and patent applications from 2019 to 2023 wherein no accompanying journal article has been published, with a focus on examples that enable chemistries that are difficult or unsafe to scale in batch mode or provide significant process intensification.
“…In their patent that described the electrochemical process, Bayer inventors noted that pyridine 15 exists as a mixture of two atropisomers due to hindered rotation. , The electrochemical or chemical oxidation of the undesired enantiomer ( R )- 14 leads to an ( R )- 15 :( S )- 15 ratio of about 15:85. Electrochemical reduction of this mixture leads to a similar ( S )- 15 :( R )- 15 ratio, thereby regenerating a high percentage of the undesired ( R )- 14 enantiomer.…”
Flow chemistry reactions and continuous separations have become established processing modalities in the pharmaceutical industry from early development to manufacturing. The current review highlights patents and patent applications from 2019 to 2023 wherein no accompanying journal article has been published, with a focus on examples that enable chemistries that are difficult or unsafe to scale in batch mode or provide significant process intensification.
“…8 For example, ruthenium catalysts with a chiral diamine ligand (Figure 1a , left) promote the highly stereoselective reduction of quinolines, 9 10 11 12 isoquinolines, 13 quinolizidines, 14 benzoxazines, 15 and indoles. 16 17 The hydrogenation of arenes has also been broadly utilized in total syntheses of natural products, 18 19 20 21 further demonstrating the power of this strategy.…”
Section: Table 1
Optimization Of the Selective Hydrogen...mentioning
A bioinspired formal synthesis of montanine-type Amaryllidaceae alkaloid pancracine through selective hydrogenation of 3-aryl indole derivative is disclosed. The key features of the current synthesis include hexahydroindole synthesis via chemo-selective hydrogenation of aryl-substituted indole and a diastereoselective silyl hydride reduction of an iminium intermediate, which is generated from enaminone via Tf2O activation. The eight-step assembly of the 5,11-methanomorphanthridine framework represents a novel and efficient strategy that enables one of the shortest syntheses of pancracine so far.
“…27 28 29 For these systems, numerous computational studies have now generated a good mechanistic understanding that permits the stereoselectivity to be rationalized in many cases. 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 Consequently, several articles have compiled reaction lists that can be explained by models derived from computational studies. 17 34 , 53 54 55 56 57 However, no comparable catalogue exists for chiral phosphates.…”
Recent strategies for enantioinduction often focus on employing a chiral catalyst to noncovalently interact with the substrate. By restricting the number of low energy diastereomeric transition states the reacting components can adopt, stereoselectivity can be achieved. Many of these noncovalent interactions include a significant dispersive component and these types of contacts have historically been difficult to model accurately. Modern computational methods have been designed to overcome such limitations. Using our computational work in chiral phosphate catalysis, we discuss the reasons for enantioselectivity in diverse reaction space.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.